Author

Yukthi P. Suresh

Vanderbilt University Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexandra A. Abu-ShmaisiD· 2 shared Alexis K. JankeiD· 2 shared Ivelin S. GeorgieviD· 2 shared James E. CroweiD· 2 shared Lindsay E BassiD· 2 shared Rachel H. BonamiiD· 2 shared Robert H. CarnahaniD· 2 shared Ahmed Magdy KhaliliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alexandra A. Abu-ShmaisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein

Alexandra A. Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, Sabina E W Leonard, Rose J. Miller, Alexis K. Janke, Matthew J. Vukovich, Lindsay E Bass, Yukthi P. Suresh, Scott A. Rush, Rachael M. Wolters, Nurgun Kose, Robert H. Carnahan, James E. Crowe, Rachel H. Bonami, , Ivelin S. Georgiev

The paper identifies a human antibody that neutralizes RSV and hMPV by targeting a novel epitope spanning multiple antigenic sites, showing cross-protection in a mouse model.

Cell Reports Medicine · Jan 16, 2026Peer-reviewedImmunology

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

Parker J. Jamieson, Xiaoying Shen, Alexandra A. Abu-Shmais, Perry T. Wasdin, Katarzyna Janowska, Robert J. Edwards, Garrett Scapellato, Maurice Bukenya, Lindsay E Bass, Simone I. Richardson, Nelia P. Manamela, Shuying Liu, Maggie Barr, Lindsey Adams, Cristina Paola Velez-Castro, , Ivelin S. Georgiev

The paper isolates glycan-reactive antibodies from HIV-1 vaccine trial participants and finds they neutralize diverse HIV strains and show broad cross-reactivity against other pathogens.

Journal of Virology · Nov 10, 2025Peer-reviewedImmunology